Pernix Therapeutics Holdings, Inc. (PTX)
-NasdaqGM | Prev Close: | 3.88 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 6.25 |
|---|
| Beta: | 1.77 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 2.93 - 9.20 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 70,475 |
|---|
| Market Cap: | 145.90M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.35 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 3 Health Care Stocks Under $10 to Watchat TheStreet(Tue, Jun 18)
- PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued ListingEDGAR Online(Thu, Jun 13)
- PERNIX THERAPEUTICS HOLDINGS, INC. FinancialsEDGAR Online Financials(Fri, May 17)
- Pernix Reports Loss in 1QZacks(Mon, May 13)
- PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a DireEDGAR Online(Mon, May 13)
- Pernix Therapeutics Holdings Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Fri, May 10)
- Pernix Therapeutics appoints Michael Pearce as President and CEOtheflyonthewall.com(Fri, May 10)
- PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 10)
- Pernix Therapeutics Reports First Quarter 2013 Financial ResultsBusiness Wire(Fri, May 10)
- Q1 2013 Pernix Therapeutics Holdings Inc Earnings Release - Before Market OpenCCBN(Fri, May 10)
- Pernix Therapeutics to Report First Quarter 2013 Financial Results on May 10, 2013Business Wire(Fri, May 3)
- PERNIX THERAPEUTICS HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, FinanEDGAR Online(Thu, Apr 25)
- Pernix Therapeutics to Present at the 12th Annual Needham Healthcare ConferenceBusiness Wire(Tue, Apr 23)
- Pernix Therapeutics Holdings Inc. Stock Downgraded (PTX)at TheStreet(Mon, Apr 22)
- Pernix Reports Loss in 4QZacks(Thu, Mar 21)
Comparison
| Symbol | % Chg | Mkt Cap |
|---|
| PTX | 0.00% | 145.90M |
| NVO |  0.11% | 87.67B |
| TEVA | 0.00% | 33.77B |
| AGN | 0.00% | 30.08B |
| FRX | 0.00% | 11.09B |
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 2.12 |
|---|
| Ex-Dividend Date: | 21-Aug-01 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.58 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.13 |
|---|
| Mean Recommendation*: | 1.7 |
|---|
| PEG Ratio (5 yr expected): | -0.28 |
|---|
Business Summary
Pernix Therapeutics Holdings, Inc. focuses on developing, manufacturing, marketing, and selling branded and generic pharmaceutical products for pediatric and adult indications in various therapeutic areas.
View More